State Street’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$133M Sell
2022
Q4
$148M Sell
2022
Q3
$93.6M Buy
2022
Q2
$13.7M Sell
2022
Q1
$37.3M Buy
2021
Q4
$17.5M Buy
2021
Q3
$4.68M Buy
2021
Q2
$3.83M Buy